These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2062033)

  • 61. [Diabetic nephropathy. Review of the current status and practical considerations concerning etiopathogenetic, clinical and therapeutic aspects].
    Martini PF; Segoloni GP; Jeantet A; Giachino G; Mangiarotti G; Nebiolo PE; Longo L; Piancino G
    Minerva Med; 1980 Oct; 71(38):2709-23. PubMed ID: 7001279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approach.
    Gilbert RE; Cox A; Dziadek M; Cooper ME; Jerums G
    J Diabetes Complications; 1995; 9(4):252-4. PubMed ID: 8573740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.
    Thomson SC; Vallon V; Blantz RC
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F8-15. PubMed ID: 14656757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.
    Eriguchi M; Lin M; Yamashita M; Zhao TV; Khan Z; Bernstein EA; Gurley SB; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
    Am J Physiol Renal Physiol; 2018 Apr; 314(4):F531-F542. PubMed ID: 29187372
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury.
    Park JH; Park J; Hwang SH; Han H; Ha H
    Transplant Proc; 2012 May; 44(4):1123-6. PubMed ID: 22564642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats.
    Yoshimoto T; Naruse M; Nishikawa M; Naruse K; Tanabe A; Seki T; Imaki T; Demura R; Aikawa E; Demura H
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E989-96. PubMed ID: 9227442
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myofibroblast involvement in tubular basement membrane remodeling in type II diabetic nephropathy.
    Mandache E; Gherghiceanu M; Serafinceanu C; Penescu M; Mircescu G
    Rom J Morphol Embryol; 2011; 52(1):75-9. PubMed ID: 21424035
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats.
    Nozako M; Koyama T; Nagano C; Sato M; Matsumoto S; Mitani K; Yasufuku R; Kohashi M; Yoshikawa T
    PLoS One; 2015; 10(11):e0143979. PubMed ID: 26606054
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Significance of tubulointerstitial changes in diabetic renal disease.
    Ziyadeh FN
    Kidney Int Suppl; 1996 May; 54():S10-3. PubMed ID: 8731186
    [No Abstract]   [Full Text] [Related]  

  • 70. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
    Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reactive oxygen species and matrix remodeling in diabetic kidney.
    Ha H; Lee HB
    J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S246-9. PubMed ID: 12874440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kidney complications.
    Brown DM; Andres GA; Hostetter TH; Mauer SM; Price R; Venkatachalam MA
    Diabetes; 1982; 31(Suppl 1 Pt 2):71-81. PubMed ID: 7160536
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Diagnosis of renal tubular dysfunction in insulin-dependent diabetes mellitus].
    Golubović E; Stefanović V; Zivić S
    Srp Arh Celok Lek; 1996; 124 Suppl 1():43-4. PubMed ID: 9102926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Glomerular diseases and diabetes mellitus].
    Hara S; Nihei H; Mimura N
    Nihon Rinsho; 1984 Jun; 42(6):1411-7. PubMed ID: 6482006
    [No Abstract]   [Full Text] [Related]  

  • 76. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determination of urinary lysozyme for potential detection of tubular dysfunction in diabetic nephropathy.
    Shima K; Hirota M; Fukuda M; Tanaka A
    Clin Chem; 1986 Oct; 32(10):1818-22. PubMed ID: 3530528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proceedings: The kidney in diabetes mellitus.
    Brewer DB
    J Clin Pathol; 1974 Nov; 27(11):928. PubMed ID: 4443413
    [No Abstract]   [Full Text] [Related]  

  • 80. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
    Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
    Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.